Related Experiment Video
Updated: Jul 16, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Low birth weight as a vulnerability marker for early drug use
Howard D Chilcoat1, Naomi Breslau
1Department of Mental Hygiene, Johns Hopkins University, Baltimore, Maryland 21205, USA. hchilcoa@jhsph.edu
Abstract:
Using prospective data from a community-based sample, the authors tested (a) whether low birth weight (LBW) was a vulnerability marker for children's early drug use and (b) whether the antecedents and sequelae of LBW may act as mediators or confounders in the pathway to early drug use. A total of 823 children and their mothers--473 LBW (<2,500 g) and 350 normal birth weight (NBW)--were assessed when the children were 6 years old and again when they were 11 years old. The incidence of drug use was higher in LBW versus NBW boys (relative odds = 2.0, 95% confidence interval = 1.2-2.6), but there was no difference in incidence for girls. The increased risk for LBW boys remained after adjustment for IQ, externalizing problems, attention-deficit/hyperactivity disorder, and maternal smoking. These findings suggest that LBW is a useful vulnerability marker for early drug use among boys, independent of the antecedents and sequelae of LBW.
More Related Videos
Related Concept Videos
Factors Affecting Drug Response: Overview
Drug Dependence
Drug Abuse and Addiction: Pharmacological Phenomena
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Toxicity: Risk factors
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.

